J.P.Morgan Chase & Co.

J.P. Morgan Chase & Co. is out with a research report on Mellanox Technologies (NASDAQ: MLNX) and it has a Neutral rating and a $37 price target on shares. In a note to clients, J.P.Morgan Chase & Co. writes, "Mellanox reported 3Q results that were in line with ours and the consensus...

J.P. Morgan Chase & Co. is out with a research report on Comtech Telecommunications (NASDAQ: CMTL) and it has an Overweight rating and a $31 price target on shares. In a note to clients, J.P. Morgan Chase & Co. writes, "Despite an EPS beat, CMTL's quarter was largely as expected, with the...

J.P.Morgan Chase & Co. is out with a research report on FactSet Research Systems (NYSE: FDS) and it has a Neutral rating, but is raising its price target to $100 from $80. In a note to clients, J.P. Morgan writes, "We are maintaining our Neutral rating on FactSet shares following FQ4,11...

J.P.Morgan Chase & Co. is downgrading shares of Pacific Biosciences Inc. (NASDAQ: PACB) to Underweight from Neutral, and it has a $8 price target. In a note to clients, J.P.Morgan Chase & Co. writes, "In an 8-K filed after the close, Pacific Biosciences (PACB) announced that it is cutting...

J.P.Morgan Chase & Co. is out with a research report on FXCM (NASDAQ: FXCM) and it has an Overweight rating and a $15 price target on shares. In a note to clients, J.P.Morgan Chase & Co. writes, "FXCM released its August operational metrics, reporting expectedly higher trading volume,...

J.P.Morgan Chase & Co. is out with a research report on H.J. Heinz Co. (NYSE: HNZ) after it reported earnings, and is lowering its price target to $57 from $60, but is keeping its Overweight rating. In a note to clients, J.P.Morgan Chase & Co. writes, "Heinz yesterday reported adjusted...

J.P.Morgan Chase & Co. is out with a research report on Williams-Sonoma, Inc. (NYSE: WSM) and is lowering its price target to $37 from $41, but is keeping its Neutral rating on shares. In a note to clients, J.P.Morgan Chase & Co. writes, "We believe today's results and guidance...

J.P.Morgan Chase & Co. is out with a research report on Republic Services Inc (NYSE: RSG) and it has an Overweight rating and a $35.50 price target on shares. In a note to clients, J.P.Morgan Chase & Co. writes, "RSG reiterated comments made on its recent Q2 call, indicating that while...

J.P.Morgan Chase & Co. is initiating coverage on LinkedIn (NYSE: LNKD) with an Overweight rating and a $85 price target. In a note to clients, J.P.Morgan Chase & Co. writes, "We are initiating coverage of LinkedIn with an Overweight rating and a price target of $85. Shares are trading 70%...

J.P. Morgan is out with a research report on the Community Health Systems Inc (NYSE: CYH), Tenet Healthcare Corporation (NYSE: THC) deal. It has a Neutral rating on shares of Community Health Systems. In a note to investors, J.P. Morgan writes, "This morning, CYH raised its offer for THC to $7.25...

Morgan Stanley has raised its EPS estimates and is maintaining its Overweight rating and $61 price target after J.P. Morgan Chase & Co. (NYSE: JPM) showed another strong quarter. In the report, Morgan Stanley writes, “Several underlying trends that together show JPM's drive to grow quality...

Morgan Stanley has raised its EPS estimates and is maintaining its Overweight rating and $61 price target after J.P. Morgan Chase & Co. (NYSE: JPM) showed another strong quarter. In the report, Morgan Stanley writes, “Several underlying trends that together show JPM's drive to grow quality...

J.P. Morgan Chase & Co. is maintaining its Overweight rating and $47 price target on shares of Carnival Corporation (NYSE: CCL). In a note to investors, J.P. Morgan writes, "We believe CCL management has taken the proper steps to mitigate the financial impact from the MENA region by canceling...

J.P. Morgan Chase & Co. has a Neutral rating and a $22 price target on shares of NTELOS (NASDAQ: NTLS) after it reported earnings. In a note to clients, J.P. Morgan writes, "NTELOS reported mixed 4Q10 results. Revenue and EBITDA were generally positive, though subscriber results were...

J.P. Morgan Chase & Co. has an Overweight rating and a $31.50 price target on shares of Invesco Ltd. (NYSE: IVZ). In a note to clients, J.P. Morgan writes, "We reiterate our Overweight rating on Invesco as we see it both as a multiple expansion story based on improving sales, and an earnings...